AN2 Therapeutics, Inc. Common Stock (ANTX)

Typically moves ±9.21% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-11-12 ESTIMATED
search

AN2 Therapeutics, Inc. Common Stock (ANTX) has a 16-report earnings history dating back to May 10, 2022. Its average absolute post-earnings move is ±9.21%, and 50.0% of those reactions were positive. Its largest post-earnings gain was +64.54% (Aug 11, 2022) and its largest decline was -9.32% (May 11, 2026). The next earnings report is predicted for 2026-11-12 (estimated).

Earnings reactions

How ANTX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

16

Avg Abs. Movement

±9.21%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 11, 2026 ☽ POST +6.53% open_in_new
May 11, 2026 ☽ POST -9.32% open_in_new
Mar 17, 2026 ☽ POST -7.69% open_in_new
Nov 12, 2025 ☽ POST +0% open_in_new
event

Earnings Count

16

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.21%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 16 →
16
Funds holding
$15588808
Total value held
Buying
14 added · 2 reduced
Blackrock, Inc.
$8060991 +422.48%
Ameriprise Financial Inc
$2599390 NEW BUY
State Street Corp
$1508154 +170.48%
Northern Trust Corp
$1040217 +397.55%
Bank Of America Corp /De/
$705686 -62.97%

Frequently asked about ANTX earnings

When does AN2 Therapeutics, Inc. Common Stock report earnings next? expand_more

AN2 Therapeutics, Inc. Common Stock (ANTX)'s next earnings date is estimated for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ANTX stock move after earnings? expand_more

Over 16 reports, ANTX has moved an average of ±9.21% the session after earnings, closing higher 50.0% of the time.

What was ANTX's biggest post-earnings move? expand_more

ANTX's largest post-earnings gain on record was +64.54% on Aug 11, 2022, and its largest decline was -9.32% on May 11, 2026.

Where can I find AN2 Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of AN2 Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.